)
Glenmark launches COVID-19 drug in India
Glenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
Glenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)